Welcome to




The objective of our department’s clinical and scientific research is to improve the field of ophthalmology and pioneer new treatment options for the full spectrum of pediatric ophthalmologic diseases and conditions.  From our basic scientific research laboratories at Albert Einstein College of Medicine to our ophthalmic clinical trials units, we emphasize a "bench to bedside" approach to advanced medical care.

We are currently focused on research to:   

Develop An International Glaucoma Registry

In this initiative, clinicians who are treating patients with glaucoma will complete a registry paper that will then go into a large bank of glaucoma patients. The goal is to ultimately provide researchers with a substantial bank of glaucoma patients that they can follow throughout the course of their treatment for this disease. Our hope is that the analysis of this data will help us uncover clues as to how to best manage and treat glaucoma.

Develop A Comprehensive Registry Of Pediatric Cataract Patients

The goal is to compose a large data bank of patients with cataracts in order to help researchers gather information to further the effective treatment of children and adolescents suffering from this debilitating condition. 

Test Anti-Inflammatory Medication For Use In Cataract Surgery

When cataract surgery is performed, our team uses an anti-inflammatory agent to decrease the amount of inflammation that the surgery will cause. We are currently researching the value of an anti-inflammatory medication that has not been tested before.


Determine The Effectiveness Of The Use Of Patches For Exotropia

Exotropia is a form of strabismus (eye misalignment) that causes the eyes to turn outward. We are participating with other centers of excellence in a national study to ascertain whether or not the patching of one or both eyes for several hours a day will increase the strength of the eye that is not patched. The aim is to assess the effectiveness of patching as a means to either stabilize or improve exotropia in pediatric patients.  


Active Clinical Trials

Trial Description
Disease / Condition
Principal Investigator
Trial DescriptionAn Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts - Click here for more information15-10-432-01
Disease/ConditionGenetic Disorders
Ophthalmic Diseases and Disorders
Principal InvestigatorNorman Medow, MD
Contact Jose Rosado

Email Contact
View all Clinical Trials